Patents by Inventor Timothy M. Acker

Timothy M. Acker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazoline Dihydroquinolones, Pharmaceutical Compositions, and Uses
    Publication number: 20210380559
    Abstract: This disclosure relates to pyrazoline dihydroquinolone derivatives, pharmaceutical compositions, and uses. In certain embodiments, the compounds are selective NMDA receptor inhibitors and are useful in therapeutic methods related thereto. In certain embodiments, this disclosure relates to pharmaceutical compositions comprising a compound of the following formula: or salts, esters, or prodrugs thereof, as provided herein.
    Type: Application
    Filed: August 17, 2021
    Publication date: December 9, 2021
    Inventors: Timothy M. Acker, Dennis C. Liotta, Stephen F. Traynelis, Yao Jing
  • Pyrazoline dihydroquinolones, pharmaceutical compositions, and uses
    Patent number: 11117882
    Abstract: This disclosure relates to pyrazoline dihydroquinolone derivatives, pharmaceutical compositions, and uses. In certain embodiments, the compounds are selective NMDA receptor inhibitors and are useful in therapeutic methods related thereto. In certain embodiments, this disclosure relates to pharmaceutical compositions comprising a compound of the following formula: or salts, esters, or prodrugs thereof, as provided herein.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: September 14, 2021
    Assignee: Emory University
    Inventors: Timothy M. Acker, Dennis C. Liotta, Stephen F. Traynelis, Yao Jing
  • Pyrazoline Dihydroquinolones, Pharmaceutical Compositions, and Uses
    Publication number: 20180346445
    Abstract: This disclosure relates to pyrazoline dihydroquinolone derivatives, pharmaceutical compositions, and uses. In certain embodiments, the compounds are selective NMDA receptor inhibitors and are useful in therapeutic methods related thereto. In certain embodiments, this disclosure relates to pharmaceutical compositions comprising a compound of the following formula: or salts, esters, or prodrugs thereof, as provided herein.
    Type: Application
    Filed: August 2, 2018
    Publication date: December 6, 2018
    Inventors: Timothy M. Acker, Dennis C. Liotta, Stephen F. Traynelis, Yao Jing
  • Pyrazoline Dihydroquinolones, Pharmaceutical Compositions, and Uses
    Publication number: 20160368897
    Abstract: This disclosure relates to pyrazoline dihydroquinolone derivates, pharmaceutical compositions, and uses. In certain embodiments, the compounds are selective NMDA receptor inhibitors and are useful in therapeutic methods related thereto. In certain embodiments, this disclosure relates to pharmaceutical compositions comprising a compound of the following formula: Formula (I) or salts, esters, or prodrugs thereof, as provided herein.
    Type: Application
    Filed: June 27, 2014
    Publication date: December 22, 2016
    Applicant: Emory University
    Inventors: Timothy M. Acker, Dennis C. Liotta, Stephen F. Traynelis
  • Subunit Selective NMDA Receptor Antagonists For The Treatment Of Neurological Conditions
    Publication number: 20110319416
    Abstract: Provided are compounds, pharmaceutical compositions and methods of treating or preventing disorders associated with NMDA receptor activity, including schizophrenia, Parkinson's disease, cognitive disorders, depression, neuropathic pain, stroke, traumatic brain injury, epilepsy, and related neurologic events or neurodegeneration. Compounds of the general Formulas A-E, and pharmaceutically acceptable salts, esters, prodrugs or derivatives thereof are disclosed.
    Type: Application
    Filed: January 28, 2010
    Publication date: December 29, 2011
    Applicant: EMORY UNIVERSITY
    Inventors: Stephen F. Traynelis, Dennis C. Liotta, Cara Mosley, Timothy M. Acker, Sommer Zimmerman